Sort
39,280 grants matching “leukemia”
Chromatin Insulators for Human Gene Therapy
$491,410George Stamatoyannopoulos · University Of Washington · P01 · FY2011 · HL
Creating a transient metabolic catastrophe for AML therapy
$491,357Boaz Tirosh · Case Western Reserve University · R01 · FY2025 · CA
Mechanisms of Cellular Transformation by HTLV-1
$491,219Kuan-Teh Jeang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Targeting IRAK1/4 in Myelodysplastic Syndromes
$491,203Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · DK
Lifecourse determinants and outcomes of epigenetic age acceleration across two generations
$491,144Christopher Kuzawa · Northwestern University · R01 · FY2021 · AG
Predictors of Adult Leukemia
$491,008Julie Ann Ross · University Of Minnesota · R01 · FY2007 · CA
Oral Chemotherapy Adherence Trajectories in Chronic Myeloid Leukemia
$490,918Katherine Aylward Yeager · Emory University · R01 · FY2020 · CA
Hematologic Malignancies/BMT
$490,872Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2012 · CA
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
$490,809Paul Michael Armistead · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
Oral Chemotherapy Adherence Trajectories in Chronic Myeloid Leukemia
$490,715Katherine Aylward Yeager · Emory University · R01 · FY2021 · CA
VCU Minority-Based Community Clinical Oncology Program
$490,679John D Roberts · Virginia Commonwealth University · U10 · FY2011 · CA
BCL11B activation as an approach for enhancing the efficacy of immunotherapy
$490,646Chintan Parekh · Beckman Research Institute/City Of Hope · R01 · FY2025 · AI
Regulation of Mast Cell Proteases
$490,607Richard L Stevens · Brigham And Women'S Hospital · P01 · FY2007 · HL
Selectively Targeting Oncogenic NRAS in Cancer
$490,596Kevin M Shannon · University Of California, San Francisco · R01 · FY2024 · CA
Core B: Pharmaceutical Production
$490,543Brenda Marie Sandmaier · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
Risk for Psychopathology and Neurocognitive Impairment in Leukemia Survivors
$490,478Kevin R Krull · St. Jude Children'S Research Hospital · R01 · FY2014 · MH
HMGA Chromatin Remodeling Proteins in Tumor Progression in Myeloproliferative Neoplasms (MPN)
$490,434Linda M S Resar · Johns Hopkins University · R01 · FY2018 · HL
MACROMOLECULAR STRUCTURE DETERMINATION - GENERAL USERS
$490,344Robert M Sweet · Brookhaven Science Assoc-Brookhaven Lab · P41 · FY2007 · RR
The COMPASS family of H3K4 methylases in development and cancer
$490,235Ali Shilatifard · Northwestern University At Chicago · R01 · FY2015 · CA
DISSECTING THE ROLE OF PRDM15 IN NORMAL HEMATOPOIESIS AND B-CELL MALIGNANCIES
$490,068Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation
$490,048Joseph M Ready · Ut Southwestern Medical Center · R01 · FY2019 · CA
Targeting DNA repair to eradicate TKI-refractory/resistant CML
$490,024Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2018 · CA
Studies on peripheral B lymphocyte development
$490,015Shiv Subramaniam Pillai · Massachusetts General Hospital · R01 · FY2008 · AI
Molecular Mechanisms of MDS pathogenesis with aging
$490,000Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2025 · AG
Stanford University NCTN- Network Lead Academic Site
$490,000Heather Ann Wakelee · Stanford University · U10 · FY2016 · CA